Abstract The knock-in mouse is a powerful tool for biological research, but the stability of expression of an integrated gene strongly depends on where it is integrated in the mouse genome. At present, there are an insufficient number of loci suitable for gene knockin, such as the Rosa26 locus. Therefore, in this study, we developed an efficient strategy for identifying genome loci suitable for gene knock-in and characterized the properties of such loci for gene integration. For efficient discovery and characterization, we constructed a new gene-trapping vector that enables monitoring of the expression of both trapped and integrated genes using fluorescence. We successfully obtained fluorescent-positive mouse embryonic stem cell (mESC) clones with the vector. Thorough analysis of the expression of fluorescent proteins in chimera embryos generated with the obtained mESC clones, some of the gene-trapped chimera embryos showed stable and ubiquitous expression of the integrated gene. Furthermore, adult mice derived from one of the gene-trapped mESC clones showed ubiquitous expression of the integrated gene in various tissues without any unusual phenotype. This indicated that the identified locus possesses high potential for foreign gene integration. Our strategy allows for efficient discovery and characterization of mouse genome loci for gene integration.
Introduction
The transgenic mouse is one of the most powerful tools for investigating the functions of genes of interest. Gene knock-in strategy is frequently used to generate human disease models, including humanized animals. Whether an integrated gene can be stably expressed as designed strongly depends on where the gene is integrated in the vast mouse genome because of ''position effect variegation (PEV)'' regarding the Electronic supplementary material The online version of this article (doi:10.1007/s11248-015-9872-x) contains supplementary material, which is available to authorized users. integration site (Jasin et al. 1996; Garrick et al. 1998 ). In addition, it is also required that insertion of exogenous genes does not affect the mouse phenotype to properly assess the gene function and prepare disease model mice.
As a genome region suitable for gene knock-in, the Rosa26 locus was identified in 1991 and has been most commonly used to integrate exogenous genes into the mice genome (Friedrich and Soriano 1991) . Rosa26 is an ideal genome locus for gene integration because a gene integrated into the locus is expressed stably in most tissues. Moreover, there is no functional gene in the neighbourhood of the knock-in target site of Rosa26, meaning that integration of exogenous genes would not affect the mouse phenotype (Soriano 1999; Tchorz et al. 2012 ). An endogenous Rosa26 promoter could be also used for ubiquitous and strong expression of exogenous genes (Soriano 1999) . The region of the Hprt gene is also often used for gene integration in mice (Bronson et al. 1996) . However, its location in the X chromosome leads to restriction in mating or producing homogenous mice. Other than above two loci, the regions of b-actin (Shmerling et al. 2005; Jägle et al. 2007 ) and type I collagen (Beard et al. 2006 ) genes are also occasionally used. In these cases, integration of exogenous genes into these loci might lead to undesired phenotypes, especially in homozygous mice. Recently, new genome editing tools, such as zinc-finger nuclease (ZFN; Meyer et al. 2010) , transcription activator-like effector nuclease (TALEN; Sommer et al. 2014) , and CRISPER/Cas9 (Yang et al. 2013) , or recombinase-and integrasebased transgenesis (Ohtsuka et al. 2010; Tasic et al. 2011) have made it easier to insert exogenous genes into on-target loci. However, the number of ideal genome regions for gene knock-in is insufficient, and there is a need to identify novel genome loci suitable for gene knock-in.
Many gene trap projects have been carried out (Stanford et al. 2001; Araki et al. 2009; Friedel and Soriano 2010; Guan et al. 2010 ). The Rosa26 locus was identified through a previous gene trap project. However, the methods developed in these projects were not aimed at discovering genome loci but for gene knockout. In the past studies, the beta-galactosidase gene was usually used to monitor the expression of trapped genes (Friedel and Soriano 2010) . While suitable for highsensitivity detection, the beta-galactosidase gene does not allow for real time observation due to cumbersome staining. Moreover, assessing the stability of exogenous gene expression was not the aim of these studies. Thus, re-evaluation of a newly discovered region was also needed.
In this study, we used a new gene-trapping vector that enables detection of the trapped and exogenous gene expression in real time. By efficient evaluation of the trapped region using mouse embryonic stem cells (mESC) and chimera embryos, we succeeded in discovering new genome loci for gene integration. The present study demonstrates an efficient strategy for discovering new genome loci for gene integration and evaluating the candidates.
Materials and methods

Construction of the gene-trapping vector
The gene-trapping vector consisted of two fluorescent proteins and one constitutive promoter (Fig. 1) . Human elongation factor 1 alpha (EF1a) promoter sequence was excised from pCDH-EF1-MCS-T2A-copGFP plasmid (System Biosciences). Enhanced green fluorescent protein (EGFP) and mCherry genes were excised from pEGFP-N1 plasmid (Clontech) and pmCherry-C1 plasmid (Clontech), respectively. The splicing acceptor (SA) sequence (Krizman and Berget 1993) , neomycin resistant gene (neo), and simian vacuolating virus 40 early polyadenylation signal sequence (SV40pA) were amplified by polymerase chain reaction (PCR) from neo cassette (Katoh et al. 1987) . The self-cleaving peptide sequence (T2A; Szymczak et al. 2004 ) was synthesized as an oligonucleotide flanked with the neo sequence. The flanked sequence of T2A was as follows: 5 0 -GAGGGCA GAGGAAGTCTTCTAACATGCGGTGACGTGGA GGAGAATCCCGGCCCT-3 0 . The bovine growth hormone polyadenylation signal (BGHpA) was also amplified from pcDNA3.1 ? plasmid (Life Technologies). These DNA fragments were cloned by DNA Ligation Kit (Takara Bio) or In-Fusion cloning kit (Clontech). Primers used in amplifying fragments are listed in Online Resource 1, Table 1 . We confirmed that there was no mutation in the constructed gene-trapping vector by sequencing analysis with 3130xl genetic analyser (Life Technologies). Before electroporation, the gene-trapping vector was linearized by restriction enzymes.
Establishment and maintenance of mouse embryonic stem cells
We established mouse embryonic stem cell (mESC) lines from blastocysts of C57BL/6J mouse (CLEA Japan) and certified the pluripotency of the established mESC lines as described elsewhere (Andras et al. 2003) . The established mESC was maintained on neomycin-resistant mouse embryonic fibroblasts (Millipore) treated with mitomycin C (Nacalai tesque) in Knockout DMEM with 15 % KnockOut Serum Replacement, 5 % fetal bovine serum embryonic stem cell-qualified, 19 MEM non-essential amino acids solution, 55 nM 2-mercaptoethanol (these were from Life Technologies), 1.7 9 10 3 unit/ml mouse leukemia inhibitory factor, 19 ES cell qualified nucleosides (these were from Millipore), and the appropriate antibiotics.
Electroporation of gene-trapping vector and selection of mESC clones Linearized gene-trapping vector (16 lg per program) was transduced into mESCs (2-3 9 10 6 cells per program) by electroporation procedure using Nucleofector kits for mouse embryonic stem cells (Lonza). The recombinant mESC clones were selected with 200 ng/ml of G418 (Geneticin; Life Technologies) in the culture medium. After 6 days of selection, fluorescent signal of mESC colonies was observed under a fluorescent microscope (Axio Observer, Carl Zeiss). Some fluorescent-positive colonies were picked up and expanded.
Generation and observation of chimera embryos Chimera embryos were generated by aggregation procedure as described elsewhere (Andras et al. 2003) . Briefly, mESC clones were co-cultured with an eightcell stage embryo from ICR mice (CLEA Japan). After overnight co-culture, chimera embryos were transplanted into pseudo-pregnant mice (ICR from CLEA Japan). The chimera embryos were harvested at day E12.5. The chimera embryos were fixed in phosphate-buffered 4 % paraformaldehyde (Wako) overnight at 4°C. Fluorescence was detected with a VB-G05 fluorescent macromicroscope (Keyence).
Identification of integration site
The integration site of the gene-trapping vector in the mouse genome was identified by 5 0 rapid amplification of cDNA ends (5 0 RACE) with a GeneRacer kit (Life Technologies) or by genomic primer walking with GenomeWalker Universal kit (Clontech) as directed. To determine the breakpoint in the obtained clones, PCR was performed using a vector-specific primer and several genome specific primers. The PCR product was sequenced in 3130xl genetic analyser (Applied Biosystems). Primers are listed in Online Resource 1, Generation, maintenance, and observation of genetrapped mice
To produce gene-trapped mice, chimera mice were generated from gene-trapped mESC clones by aggregation procedure described above. The obtained chimera mice were crossed with wild type C57BL/6J mice (CLEA Japan) to produce heterozygous genetrapped mice. Homozygous gene-trapped mice were generated by inbreeding of heterozygous mice. Genotyping of the mice was performed by PCR with genomic DNA extracted from their tails using KOD Fx DNA polymerase (Toyobo). Tissues from gene-trapped mice were fixed in phosphate-buffered 4 % paraformaldehyde (Wako) overnight at 4°C and observed under the VB-G05 fluorescent macro-microscope (Keyence). Maintenance, breeding, and experiments of all mice were carried out in a manner approved by the institutional animal care and use committee at Tottori University and Shionogi & Co., Ltd.
Histological analysis
For histological analysis, the tissues excised from heterozygous and homozygous gene-trapped mice were first fixed in 4 % paraformaldehyde in PBS for 4 h at 4°C and immersed in a 10-30 % sucrose concentration ascending series in PBS for several hours at 4°C. The fixed tissues were embedded in O.T.C. compound (Sakura Finetek) and frozen on dry ice. Embedded tissues were sectioned with CM1950 cryostat microtome (Leica) to 10 lm thick. After blocking with Blocking One Histo (Nacalai tesque) for 20 min at room temperature, sections were incubated with a 1:1000 dilution of anti-GFP Rabbit IgG Polyclonal Antibody Fraction (Lifetechnologies, A-11122) overnight at 4°C. They were then incubated with a 1:500 dilution of AlexaFluor 488-conjugated anti-rabbit IgG antibody (Lifetechnologies, A-11008) for 1 h at room temperature. Nuclear staining was performed by immersing with 100 ng/ml of 4 0 , 6-diamidino-2-phenylindole (DAPI) in TBS. Fluorescent signal was observed and photographed with a confocal laser scanning microscopy LSM700 and a digital camera AxioCam MRm (Carl Zeiss) under the same condition in each tissue.
Results
Construction of the gene-trapping vector
To efficiently discover ideal loci for gene integration, we constructed an engineered gene-trapping vector (Fig. 1) . The vector contained two fluorescent protein genes. One fluorescent protein was EGFP expressed under the EF1a promoter that enabled monitoring of the stability and intensity of the exogenous gene in real time. The other one was mCherry located after the SA sequence that enabled monitoring of the stability and intensity of the genes trapped by the trapping vector. Using the gene-trapping vector, we assessed two aspects of the trapped loci at a time: whether the integrated gene was expressed ubiquitously and stably as designed and whether the trapped gene was expressed in mESC. We used the gene-trapping vector in vitro and in vivo to discover new loci for gene integration.
Gene trap in mouse embryonic stem cells
To discover new loci for gene integration in vitro, we performed the gene-trapping experiment with mESC. The linearized gene-trapping vector was introduced into mESC by electroporation. After selection with G418, the gene-trapped mESC colonies exhibited various expression patterns of EGFP and mCherry; some colonies expressed both fluorescent proteins and others expressed only one or neither (Fig. 2a) . We counted the number of mESC colonies expressing EGFP or mCherry or both using fluorescent microscopy. Of the surviving colonies, 89.0 % were EGFP positive, 3.3 % were mCherry positive, and 7.8 % were positive for both (Fig. 2b) . No fluorescence was observed in 17.6 % of the surviving mESC colonies. There were no significant differences in the number of total colonies and percentage of GFP or mCherry visible colonies between the digestion points of the gene-trapping vector (data not shown). Unexpectedly, the fluorescence of mCherry was slightly visible or invisible in most colonies of the surviving mESC colonies, although mCherry and neo genes were linked through the T2A sequence, indicating that two genes were expressed at similar levels. To confirm whether or not the fused gene of mCherry and neo was sufficiently expressed, the amount of mRNA was measured. Expression of mCherry mRNA was detected to some extent even in mCherry-invisible colonies, indicating that the fused gene was sufficiently expressed to acquire resistance to G418 (Online Resource 1, Fig. S1 ). Notably, about three-fourths of EGFP-visible colonies displayed mosaic expression of EGFP (Fig. 2b, c) . Because such mosaic expression of EGFP in a single mESC colony could indicate that the trapped loci were unstable in terms of chromatin formation, we abandoned these clones in subsequent colony selection. We selected 12 clones of mESCs exhibiting both EGFP and mCherry signals and expanded them to produce chimera embryos.
Characterization of trapped loci
We next characterized the trapped loci using chimera embryos (Fig. 3a) . Gene-trapped mESCs were cocultured with eight-cell embryos of wild type mice to make chimera embryos. The chimera embryos were observed at 12 days after fertilization. Completely black-eyed chimera embryos showed approximately 100 % contribution of mESC in the embryonic body. Consequently, 11 of the 12 mESC clones were successfully subjected to in vivo analysis. In seven of the 11 clones, stable and ubiquitous expression of EGFP was detected ( Fig. 3b and Online Resource 1, Fig. S2 ). Especially in clone #3A2, 3A11, and 3B11, strong GFP expression was detected. Results from genomic real-time PCR and Southern blot indicated Fig. 3 Characterization of trapped loci. a Schematic diagram of our experiment using chimera embryos. Fertilized eggs derived from ICR (red-eyed) and mESC derived from C57BL/6 (black-eyed) were co-cultured for 2 days and transplanted to host mice. Completely black-eyed embryos indicate high contribution of mESC. b Representatives of gene-trapped chimera embryos. Chimera embryos were observed under the same conditions of the fluorescence microscope. ''Wild'' means wild type embryos and ''Trapped'' means gene-trapped chimera embryos. Note the colourless eyes in wild type embryos and completely black eyes in gene-trapped embryos. No fluorescent signal of mCherry was detected in any chimera embryos. c Schematic diagram of trapped genome locus in clone #3A11. Black boxes indicate exons of the genes. Exon number is indicated above the boxes. A red box indicates trapped mRNA identified by 5 0 RACE. Arrows indicate orientation of the transcription of the genes. Fam168a: family with sequence similarity 168, member A, Plekhb1: pleckstrin homology domain containing, family B (evectins) member 1. Gm19720: predicted gene, 19720 that the trapping vector was integrated in a single-copy manner into the genomes of the clones 3A2, 3A11, 3B11, and 3D4, and in a multiple-copy manner in the clone 3H10 (Table 1 , and Online Resource 1, Fig. S4 ). The strength of the EGFP signal did not seem to be correlated with the copy number of the gene-trapping vector integrated into mESCs. The fluorescence of mCherry was not visible in all chimera embryos despite moderate expression in some mESC clones. Taken together, we were able to evaluate the trapped loci in vivo with our strategy, utilizing of the EGFP signal from the chimeric embryos.
We tried to identify where the gene-trapping vector was integrated in the mouse genome and which gene was trapped. Using 5 0 RACE and genome walking methods, the trapped genes were successfully identified in five of the seven clones (Table 1 ). In three of the five clones, trapping vectors were integrated into introns of known genes, i.e., the intron of the ubiquitin-conjugating enzyme E2Z (Ube2z) gene in clone #3B11, of the solute carrier family 45, member 3 (Slc45a3) gene in clone #3D4, and of the chloride channel 2 (Clcn2) gene in clone #3A2 (Online Resource 1, Fig. S3a-c) . On the other hand, in two of the five clones, trapping vectors were integrated into the genome loci where no gene was reported. In clone #3A11, the trapping vector was integrated into the neighbourhood of the Family with sequence similarity 168, the member A (Fam168a) gene, however, the trapped orientation was opposite to the orientation of its own transcription (Fig. 3c) . In clone #3H12, no gene or significant component was found in the neighbourhood of the integrated locus (Online Resource 1, Fig. S3d ). No abnormal shape was found in any of the chimera embryos ( Fig. 3b and Online Resource 1, Fig. S2 ).
Assessment of the discovered locus as a gene integration site
For further assessment, we focused on the clone #3A11 for the following two reasons. First, the most stable and ubiquitous EGFP expression was observed in the chimera embryos derived from the clone #3A11. Second, the integrated trapping vector wouldn't disrupt the gene structure of Fam168a, in contrast to some other clones we obtained. We determined the breakpoint of the mouse genome by the gene-trapping vector in the locus with genomic PCR and sequencing analysis. The breakpoint was identified as being approximately 1.3 kbp upstream of the first exon of the Fam168a gene (Fig. 4a) . We designated this locus as the Fam168a Neighbourhood-Locus (FN-Locus).
Next, we generated gene-trapped mice to assess the potential for expression stability of the FN-Locus as a gene integration site in adult mice. Gene-trapped chimera mice were generated from the #3A11 mESC clone by the aggregation method and crossed with wild type mice. To evaluate how stable the expression of integrated gene was, EGFP expression was observed wholly in various tissues from the genetrapped mice (Fig. 4b and Online Resource 1, Fig.  S5 ). Strong EGFP expression was observed in the testis, small intestine, liver, kidney, and pancreas. The fluorescent intensity of EGFP and mCherry was scored in a qualitative manner under a fluorescent microscope. ''??'' indicates a strong fluorescent signal, ''?'' indicates a moderate signal, and ''-'' indicates a negative one. Relative copy numbers of EGFP gene in the obtained clones were determined by genomic qPCR using the Trfc gene as an internal control. The values were relative to that of the mouse ESC in which single-copy of a cassette vector containing EGFP and Neo was integrated into the Rosa26 locus arbitrarily set to 1.00. Integration sites identified by 5 0 RACE or genomic primer walking are shown with annotations for the trapped loci. Clcn2: chloride channel 2, Fam168a: family with sequence similarity 168, member A, Ube2z: putative ubiquitin-conjugating enzyme E2Z, Slc45a3: solute carrier family 45, member 3
Transgenic Res (2015) 24:549-559 555 Through histological analysis, we confirmed a strong EGFP fluorescence on cryosections prepared from the pancreas, brain, and kidney of the gene-trapped mice and a moderate fluorescence from liver (Fig. 5) . Importantly, in all tissues analysed, the expression of EGFP was stable and ubiquitous, indicating that the gene integrated into the FN-Locus was not affected by the position-effect variegation. We also confirmed that gene integration into the locus did not cause any abnormality in the mouse phenotypes by generating homozygous gene trapped mice by inbreeding. To verify whether gene integration mouse genome gene-trapping vector (Fig. 4c) . However, no abnormality was detected in birth rate (Online Resource 1, Table S2 ), body weight (Online Resource 1, Fig. S6 ), appearance, and behaviour even in homozygous gene-trapped mice (data not shown for other phenotypes). These results indicated that gene insertion into the locus would not affect the phenotype of mice. In addition, an increase of EGFP expression in homozygous gene-trapped mice was observed when compared with heterozygous mice (Figs. 4d, 5 ). This indicated that the FN-Locus was not affected by the effect of genome imprinting. Taken together, the FN-Locus that we identified offers high potential for foreign gene integration.
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Discussion
The aim of this study was to discover ideal genome loci for gene integration in mice. First, we showed that our gene-trapping vector worked well in vitro. Second, we evaluated some trapped loci using chimera embryos and identified some candidates for gene integration sites. Finally, we confirmed that one of the genome loci we identified had high potency as a gene integration site. These results indicate that our strategy is useful for discovering new genome loci for gene integration.
In our strategy, identification of the integration sites of the gene-trapping vector was one of the most difficult steps. This is because the gene-trapping vector is occasionally integrated tandemly into one locus, thus leading to false amplification by vectorspecific primers among repeated vector sequences in RACE or genomic primer walking. Using a lentivirus vector (Friedrich and Soriano 1991) or a transposon vector (Clark et al. 2004 ) may facilitate the identification step because they usually integrate with one copy in one locus. Even so, using a plasmid vector for gene-trapping has three advantages. First, where the gene-trapping vector can be integrated is completely random and this contributes to the diversity of genome loci that can be assessed. Second, in most cases, the gene-trapping vector integrates into one genome locus. Third, multi-copy integration results in strong expression of the inserted gene, leading to easy detection of fluorescent signals. For identification of an integration site, whole-genome sequencing with next generation sequencers can be used to facilitate the identification step (Zhang et al. 2012) .
The ratio of mCherry-visible mESC colonies was unexpectedly low after transduction of the genetrapping vector (Fig. 2b) . This data indicated that the tolerance of mESCs to G418 was achieved under lowlevel expression of the neo gene, thus making the mCherry signal invisible even in surviving colonies. In addition, in our experiment, the T2A sequence was adopted for the accompanying expression of Neo with mCherry. The expression efficiency of Neo should be higher than the case in which the internal ribosome entry site (IRES) was utilized for Neo expression (Attal et al. 1999) . That was also one of the reasons for the appearance of mCherry-invisible clones after addition of G418. On the other hand, we expected that the high expression of mCherry in mESC clones reflects an open state of the trapped locus in chromatin. The open state of chromatin could not only contribute to stable expression of the integrated genes but also facilitate the integration of exogenous genes into the locus in ESCs and fertilised eggs. To discover the generally-available locus in which genes of interest can be integrated with ease, using a splice acceptorbased trap cassette has the advantage for screening. Further studies are needed in order to make sure this hypothesis.
Gene-trapped mice carrying a trapping vector within the FN-Locus exhibit stable and ubiquitous expression of EGFP (Figs. 4b, 5 , and Online Resource 1, Fig. S5 ), indicating that the locus can have high potency as a gene integration site. In the gene-trapped mice, increased expression of Fam168a was observed. It might result from promoter interference between the gene-trapping vector and the Fam168a gene or from destruction of the repressor element of Fam168a gene by vector insertion. There are few reports about the Fam168a function except for those on the possible contribution to radio sensitivity in oral squamous cell carcinoma cells (Gu et al. 2011a, b) . According to descriptions in public databases, the function of Fam168a gene was seemed to be considered less important in cell functions. In fact, we found no abnormality even in homozygous gene-trapped mice. Further accumulation of trials using this locus for gene integration should clarify the potency of this locus, i.e., whether the locus can be equal to Rosa26 and other loci. New genome editing tools should make it easier to assess the potency of the FN-Locus by gene knock-in.
Our efficient strategy utilizing chimera embryos offers the promise of finding more and better candidates when assessing more clones. In this study, we focused on discovering candidate loci for ubiquitous expression using EF1 promoter. We may be able to adapt other promoters, e.g., tissue specific promoters, to our strategy. Further analyses should be needed to clarify this possibility. The gene-trapping vector can be also used to make random gene knock-out mice. The advantage of our gene-trapping vector is the simplicity of observing the expression of trapped genes through fluorescence signals. Moreover, using well-known artificial nucleases to EGFP sequence, genes of interest can be easily integrated into our genetrapped mESC or mice by homologous recombination (Olsen et al. 2010; Shen et al. 2013 ).
In conclusion, we provide a new strategy for discovering and characterizing mouse genome loci suitable for gene integration. Using this strategy, we identified a promising locus for ubiquitous expression of integrated genes.
